Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Obstet Gynaecol Res ; 49(11): 2771-2776, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37614110

RESUMO

A 48-year-old woman underwent total abdominal hysterectomy and right salpingo-oophorectomy and was initially diagnosed with a uterine leiomyoma and right ovarian cystadenoma. After 4 years, multiple pulmonary metastases were identified, and treatment with gonadotropin-releasing hormone agonists was started, but stopped later due to disease progression. The patient developed dyspnea and underwent right upper lobectomy. The histopathological findings were consistent with those of pulmonary metastases secondary to a uterine smooth muscle tumor of uncertain malignant potential. Slow disease progression after a poor response to adriamycin and hormone receptor positivity led to the start of letrozole. Letrozole induced spontaneous regression of the pulmonary metastases, and about 2 years into the treatment, sustained response was achieved with minimal side effects. This may be the first case supporting the long-term efficacy and safety of letrozole in the management of adriamycin-resistant lung metastases of uterine smooth muscle tumors of uncertain malignant potential.


Assuntos
Neoplasias Pulmonares , Tumor de Músculo Liso , Neoplasias Uterinas , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Uterinas/cirurgia , Tumor de Músculo Liso/tratamento farmacológico , Tumor de Músculo Liso/patologia , Tumor de Músculo Liso/cirurgia , Letrozol , Neoplasias Pulmonares/patologia , Doxorrubicina , Progressão da Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA